Publication | Open Access
Influence of CYP2C9 and CYP2C19 genetic polymorphisms on pharmacokinetics of gliclazide MR in Chinese subjects
63
Citations
17
References
2007
Year
The pharmacokinetics of gliclazide MR are affected mainly by CYP2C19 genetic polymorphism instead of CYP2C9 genetic polymorphism.
| Year | Citations | |
|---|---|---|
Page 1
Page 1